NC 190, with the CAS number 120602-99-5, is a chemical compound that belongs to the class of substances known as neuroprotective agents. It is primarily studied for its potential therapeutic effects in neurological disorders. The compound exhibits properties that may help in protecting neurons from damage due to various stressors, including oxidative stress and excitotoxicity. NC 190 has been investigated for its role in modulating neurotransmitter systems, particularly in relation to neuroinflammation and neurodegeneration. Its mechanism of action may involve the regulation of specific signaling pathways that contribute to neuronal survival and function. While research is ongoing, the compound's safety profile and efficacy in clinical applications are still under evaluation. As with many experimental compounds, detailed information regarding its pharmacokinetics, toxicity, and long-term effects is essential for understanding its potential use in medical treatments. Overall, NC 190 represents a promising area of research in the field of neuropharmacology.

NC190 is a topoisomerase II-inhibitor that inhibited the growth of FM3A cells in clinical trials. NC-190 strongly inhibited the growth of FM3A cells with an IC50 of 0.019 microg/ml (0.042 microM) when cultured with NC-190 for 48 h. NC-190 potently suppressed DNA synthesis, with 90% inhibition observed at 0.1 microg/ml of NC-190.

NC 190

120602-99-5: NC 190, with the CAS number 120602-99-5, is a chemical compound that belongs to the class of substances known as neuroprotective agents. It is primarily studied for its potential therapeutic effects in neurological disorders. The compound exhibits properties that may help in protecting neurons from damage due to various stressors, including oxidative stress and excitotoxicity. NC 190 has been investigated for its role in modulating neurotransmitter systems, particularly in relation to neuroinflammation and neurodegeneration. Its mechanism of action may involve the regulation of specific signaling pathways that contribute to neuronal survival and function. While research is ongoing, the compound's safety profile and efficacy in clinical applications are still under evaluation. As with many experimental compounds, detailed information regarding its pharmacokinetics, toxicity, and long-term effects is essential for understanding its potential use in medical treatments. Overall, NC 190 represents a promising area of research in the field of neuropharmacology.

<p>NC190 inhibits topoisomerase II, halts FM3A cell growth (IC50: 0.019 μg/ml in 48h), and suppresses DNA synthesis by 90% at 0.1 μg/ml.</p>

CAS 120602-99-5

NC 190

NC190 sodium

Ref: TM-T25857